Allotera Therapeutics has welcomed Aaron Vernon as Acting Chief Technology Officer, supporting the company’s technical ...
Johns Hopkins Medicine and OpenEvidence, a medical AI platform for physicians, announced on October 13, 2026 a strategic collaboration to reimagine ...
The BioHealth Capital Region earned national recognition with eight local companies named to TIME and Statista’s World’s Top ...
BioBuzz’s Buzzin’ Brood Student Spotlight series celebrates the future of life sciences talent — and the programs, ...
TEDCO, the Maryland Technology Development Corporation, announced on October 5, 2026 that it has accepted a Federal and State ...
Citius Oncology, Inc., an oncology-focused biopharmaceutical company and majority-owned subsidiary of Citius Pharmaceuticals, Inc. (Nasdaq: CTXR), has appointed Jonathan Peri, Ph.D., J.D., as an ...
Elutia, the Gaithersburg, Maryland-based drug-eluting biomatrix company, announced it has completed the sale of its SimpliDerm® human acellular dermal matrix business to Cellution Biologics Inc. for ...
Bristol Myers Squibb is building a new $2.3 billion manufacturing campus at Generation Park in Houston, Texas, one of the larger single manufacturing investments the company has made in the U.S. in ...
Emergent BioSolutions Inc., headquartered in Gaithersburg, Maryland, announced on September 1, 2026 a contract modification valued at approximately $24 million for CYFENDUS® (Anthrax Vaccine Adsorbed, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results